Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cutaneous necrotic ulceration due to BCG re-vaccination

    Research output: Contribution to journalJournal articleResearch

  1. APMIS pandemic editorial

    Research output: Contribution to journalEditorialpeer-review

  2. Pandemics: past, present, future: That is like choosing between cholera and plague

    Research output: Contribution to journalReviewpeer-review

  3. The discovery of bacterial biofilm in patients with muscle invasive bladder cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Moderation of polymorphonuclear neutrophils (PMNs) as part of a critical defense against invading pathogens may offer a promising therapeutic approach to supplement the antibiotic eradication of Pseudomonas aeruginosa infection in non-chronically infected cystic fibrosis (CF) patients. We have observed that egg yolk antibodies (IgY) harvested from White leghorn chickens that target P. aeruginosa opsonize the pathogen and enhance the PMN-mediated respiratory burst and subsequent bacterial killing in vitro. The effects on PMN phagocytic activity were observed in different Pseudomonas aeruginosa strains, including clinical isolates from non-chronically infected CF patients. Thus, oral prophylaxis with anti-Pseudomonas aeruginosa IgY may boost the innate immunity against Pseudomonas aeruginosa in the CF setting by facilitating a rapid and prompt bacterial clearance by PMNs.

Original languageEnglish
JournalHuman vaccines & immunotherapeutics
Volume12
Issue number7
Pages (from-to)1690-9
Number of pages10
ISSN2164-5515
DOIs
Publication statusPublished - 2 Jul 2016

    Research areas

  • Journal Article

ID: 49782146